SecBot SecBot
SECBOTREPLAY Home › Report › VALN

VALN · Valneva announced participation in investor conferences (Jefferies,…

Valneva SE · 6-K filed Jun 1, 2026 at 10:00 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Jun 1, 2026 at 10:00 ET

Valneva announced participation in investor conferences (Jefferies, Oddo BHF, BNP Paribas) and a travel medicine conference, with key discussion topics including its commercial vaccines and the Lyme disease candidate LB6V (partnered with Pfizer, which reported positive Phase 3 results and plans regulatory submissions). This is a routine update with no material financial or operational data.

  • Valneva to present and hold investor meetings at Jefferies Global Healthcare Conference (June 3), Oddo BHF Nextcap Forum (June 12), and BNP Paribas SMID Cap Conference (June 24).
  • LB6V (Lyme disease vaccine candidate) partnered with Pfizer; Pfizer reported positive Phase 3 results and plans regulatory submissions.
  • Valneva will be a Gold Sponsor at the 10th Northern European Conference on Travel Medicine (June 3-5).
  • No financial figures or guidance were disclosed in the filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access